Monroe v. Medtronic, Inc.

CourtDistrict Court, D. Massachusetts
DecidedJanuary 6, 2021
Docket1:20-cv-10144
StatusUnknown

This text of Monroe v. Medtronic, Inc. (Monroe v. Medtronic, Inc.) is published on Counsel Stack Legal Research, covering District Court, D. Massachusetts primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Monroe v. Medtronic, Inc., (D. Mass. 2021).

Opinion

United States District Court District of Massachusetts

) Quanita Monroe, ) ) Plaintiff, ) ) v. ) Civil Action No. ) 20-10144-NMG Medtronic, Inc. et al., ) ) Defendants. ) )

MEMORANDUM & ORDER GORTON, J. Plaintiff Quanita Monroe (“plaintiff” or “Monroe”) alleges that Medtronic, Inc. (“Medtronic”), its subsidiaries Covidien LP and Covidien U.S. Holdings, Inc. (collectively, “Covidien”) and numerous unknown individuals involved in the manufacturing and distribution process (collectively, with Medtronic and Covidien, “defendants”) are liable for her severe internal injuries caused by a medical mesh product implanted during hernia repair surgery. Pending before the Court is defendants’ motion to dismiss plaintiff’s complaint.

-1- I. Factual Background

Medtronic is a medical device manufacturer based in Ireland with a United States principal place of business in Minnesota. In 2015, Medtronic acquired each of the medical device companies that comprise Covidien, both of which are incorporated in Delaware and have their principal places of business in Massachusetts. Covidien manufactures several different kinds of hernia mesh, including a polyester surgical mesh known as Parietex

Composite (“PCO”) mesh. PCO mesh is a two-sided composite mesh which, like other such meshes, is used to add support to muscular walls and prevent the recurrence of hernias. It has a protective absorbable collagen barrier to prevent tissue attachment on one side and a polyester textile on the other side. Defendants allegedly secured approval to market PCO mesh from the U.S. Food and Drug Administration (“FDA”) pursuant to a section of the Food, Drug and Cosmetic Act (“FDCA”) that applies

to devices found to be “substantially equivalent” in design and function to a device already legally on the market. 21 U.S.C. § 360c(f) and (i). That process, plaintiff avers, allowed

-2- defendants to forego pre-market clinical studies and research intended to ensure the safety of the product.

Monroe, a resident of Nebraska, alleges that she underwent surgery to repair an inguinal hernia in May, 2013, during which PCO mesh manufactured by defendants was implanted. She alleges that she suffered from chronic abdominal pain in the months following the surgery and that she underwent corrective surgery on an unrecalled date to remove or revise part of the implanted mesh.

In January, 2017, Monroe claims she went to the emergency room complaining of severe abdominal pain. Exploratory surgery purportedly revealed that the PCO mesh had eroded into her small intestine, requiring the immediate removal of the mesh and a portion of her bowel. Plaintiff contends that, as a result of defendants’ negligent conduct in the manufacturing and distribution of PCO mesh, she has suffered severe and permanent injuries.

II. Procedural Background Plaintiff filed her original complaint in this Court on January 23, 2020, alleging jurisdiction based upon diversity of citizenship. She amended her complaint first in February, 2020, and then again in April, 2020. In her second amended complaint

-3- (“the complaint”), plaintiff alleges 11 counts against the defendants: negligence (Count I); strict liability for defective design (Count II); strict liability for defective manufacturing

(Count III); strict liability for failure to warn (Count IV); violations of 15 U.S.C. § 2301 et seq. and Neb. Rev. Stat. § 59- 1602 et seq. (Count V); unjust enrichment (Count VI); fraudulent concealment (Count VII); negligent misrepresentation (Count VIII); negligence per se in violation of 21 U.S.C. § 33l(e) and 21 C.F.R. § 806.01(a)(l) (Count IX); vicarious liability (Count X); and punitive damages (Count XI). Defendants filed their motion to dismiss plaintiff’s complaint pursuant to Fed. R. Civ. P. 12(b)(6) and 9(b) on May

11, 2020. Pursuant to a joint motion of the parties, the case was stayed in June, 2020, pending a decision of the Judicial Panel on Multidistrict Litigation (“JPML”) as to whether to consolidate the case with 11 other pending federal actions related to Covidien’s hernia mesh products. In August, 2020, the JPML declined to consolidate the cases for coordinated pretrial treatment and defendants subsequently moved to lift the stay and renew their motion to dismiss. This Court lifted the stay in September, 2020, and plaintiff thereafter timely opposed the motion to dismiss.

-4- III. Motion to Dismiss A. Legal Standard

To survive a motion to dismiss, a claim must contain sufficient factual matter, accepted as true, to “state a claim to relief that is plausible on its face.” Bell Atl. Corp. v. Twombly, 550 U.S. 544, 570 (2007). In considering the merits of a motion to dismiss, the Court may only look to the facts alleged in the pleadings, documents attached as exhibits or incorporated by reference and matters of which judicial notice can be taken. Nollet v. Justices of Trial Court of Mass., 83 F. Supp. 2d 204, 208 (D. Mass. 2000), aff’d, 228 F.3d 1127 (1st Cir. 2000).

Furthermore, the Court must accept all factual allegations in the claim as true and draw all reasonable inferences in the claimant’s favor. Langadinos v. Am. Airlines, Inc., 199 F.3d 68, 69 (1st Cir. 2000). If the facts in the claim are sufficient to state a cause of action, a motion to dismiss must be denied. See Nollet, 83 F. Supp. 2d at 208.

Although a court must accept as true all the factual allegations in a claim, that doctrine is not applicable to legal conclusions. Ashcroft v. Iqbal, 556 U.S. 662 (2009). Threadbare recitals of legal elements which are supported by mere

-5- conclusory statements do not suffice to state a cause of action. Id.

B. Application 1. Choice of Law As a preliminary matter, this Court must determine what law applies to plaintiff’s claims. In diversity actions, a federal court must apply the law that would be applied under the choice

of law rules of the forum state. Levin v. Dalva Bros., 459 F.3d 68, 73 (1st Cir. 2006). In Massachusetts, courts apply a “functional approach” to choice of law that is “explicitly guided by the Restatement (Second) of Conflict of Laws (1971).” Id. at 74. Under that approach, tort claims are governed by the law of the state where the injury occurred unless another state has a more significant relationship to the underlying cause of action. Watkins v. Omni Life Sci., Inc., 692 F. Supp. 2d 170, 174 (D. Mass. 2010).

The parties conclude that Nebraska law should apply to plaintiff’s claim and this Court agrees. The implantation of the mesh and the subsequent injuries and treatment appear to have occurred in Nebraska, where plaintiff also resides. The only state with any other significant connection to the case is Massachusetts, where Covidien has its principal place of

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Langadinos v. American Airlines, Inc.
199 F.3d 68 (First Circuit, 2000)
Levin v. Dalva Brothers, Inc.
459 F.3d 68 (First Circuit, 2006)
Jay v. Moog Automotive, Inc.
652 N.W.2d 872 (Nebraska Supreme Court, 2002)
Rahmig v. Mosley MacHinery Co.
412 N.W.2d 56 (Nebraska Supreme Court, 1987)
State Ex Rel. Cherry v. Burns
602 N.W.2d 477 (Nebraska Supreme Court, 1999)
Freeman v. Hoffman-La Roche, Inc.
618 N.W.2d 827 (Nebraska Supreme Court, 2000)
Watkins v. OMNI LIFE SCIENCE, INC.
692 F. Supp. 2d 170 (D. Massachusetts, 2010)
Nollet v. Justices of the Trial Court of Massachusetts
83 F. Supp. 2d 204 (D. Massachusetts, 2000)
Noonan v. Wonderland Greyhound Park Realty LLC
723 F. Supp. 2d 298 (D. Massachusetts, 2010)
Scheele v. Rains
874 N.W.2d 867 (Nebraska Supreme Court, 2016)
Pearce v. Werner Enterprises, Inc.
116 F. Supp. 3d 948 (D. Nebraska, 2015)
Olsen v. Nelnet, Inc.
392 F. Supp. 3d 1006 (D. Nebraska, 2019)

Cite This Page — Counsel Stack

Bluebook (online)
Monroe v. Medtronic, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/monroe-v-medtronic-inc-mad-2021.